Assembly Biosciences, Inc. (ASMB) stock
ASMBNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/309% below fair value
$22.50+1.21 (+5.68%)
Close on Nov 17, 2026Market cap $458.11MP/E –Yield –
Assembly Biosciences price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Assembly Biosciences's price to sales ratio was 5.9× on Nov 11, 2026, against 16.1× a year earlier. Over the last 5 years it ranged from 1.8× to 47.1×, with a median of 6.4×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 5.9× | −8.5 |
| 2025 | Dec 31, 2025 | 14.5× | +10.9 |
| 2024 | Dec 31, 2024 | 3.5× | −10.0 |
| 2022 | Apr 29, 2022 | 13.5× | +11.7 |
| 2021 | Apr 30, 2021 | 1.8× | −0.6 |
| 2020 | Dec 31, 2020 | 2.4× | −33.1 |
| 2019 | Dec 31, 2019 | 35.5× | −4.6 |
| 2018 | Dec 31, 2018 | 40.0× | – |
See a number that looks wrong?